Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mattern

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuromolecular Medicine|February 5, 2023
The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's DiseaseKumar Suresh, Michael Mattern, Matthew S Goldberg, et al.
Trends in Biochemical Sciences|March 2, 2019
Using Ubiquitin Binders to Decipher the Ubiquitin CodeMichael Mattern, James Sutherland, Karteek Kadimisetty, et al.
Optics Express|December 2, 2016
Spiral phase mask shadow-imaging for 3D-measurement of flow fieldsMartin Teich, Michael Mattern, Jeremy Sturm, et al.
Journal of Medicinal Chemistry|August 3, 2017
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology TherapiesJian Wu, Suresh Kumar, Feng Wang, et al.
European Journal of Immunology|September 19, 2019
TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-bLeilani M Chirino, Suresh Kumar, Mariko Okumura, et al.
Plos One|December 14, 2017
Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60Feng Wang, Liqing Wang, Jian Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophoreChristopher S Stevenson, Elizabeth A Capper, Amy K Roshak, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuromolecular Medicine|February 5, 2023
The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson's DiseaseKumar Suresh, Michael Mattern, Matthew S Goldberg, et al.
Trends in Biochemical Sciences|March 2, 2019
Using Ubiquitin Binders to Decipher the Ubiquitin CodeMichael Mattern, James Sutherland, Karteek Kadimisetty, et al.
Optics Express|December 2, 2016
Spiral phase mask shadow-imaging for 3D-measurement of flow fieldsMartin Teich, Michael Mattern, Jeremy Sturm, et al.
Journal of Medicinal Chemistry|August 3, 2017
Chemical Approaches to Intervening in Ubiquitin Specific Protease 7 (USP7) Function for Oncology and Immune Oncology TherapiesJian Wu, Suresh Kumar, Feng Wang, et al.
European Journal of Immunology|September 19, 2019
TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-bLeilani M Chirino, Suresh Kumar, Mariko Okumura, et al.
Plos One|December 14, 2017
Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60Feng Wang, Liqing Wang, Jian Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophoreChristopher S Stevenson, Elizabeth A Capper, Amy K Roshak, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Pageof 1